License agreement with DSM Pharmaceutical Products

c-LEcta announces a license agreement with DSM Pharmaceutical Products, which grants DSM rights to c-LEcta’s proprietary alcohol dehydrogenases for enzyme-screening programs and development of sustainable manufacturing routes for producing pharmaceutical active ingredients and intermediates. DSM will also provide commercialization of sustainable enzyme-based manufacturing routes for c-LEcta.